Notice of 33rd Annual General Meeting of the company to be held on September 29, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Limited has notified its 33rd AGM to be held on Monday, September 29, 2025 at 11:00 AM via video conferencing. The AGM will cover seven items, including adoption of audited standalone and consolidated financial statements for FY 2024-25, re-appointment of Mr. Rajesh Sadhwani (Non-Executive Director) who retires by rotation, and appointment of M/s. Bilimoria Mehta & Co. as new Statutory Auditors for a 5-year term. Shareholders will also vote on revising the remuneration of Whole-Time Director & CFO Mr. Sohan Chaturvedi to Rs. 2,00,000 per month effective October 1, 2025, and on appointing M/s. Jaymin Modi & Co. as Secretarial Auditor for FY 2025-26 to 2029-30. Additionally, approval is sought for material related party transactions with wholly-owned subsidiary Clinigenome India Private Limited, up to Rs. 5 crore each for sale and purchase of goods/services, over FY 2025-26 to FY 2027-28.
Routine AGM agenda with mostly standard items, but shareholders should note the proposed 58% pay hike for the CFO (from Rs. 12.72 lakh to Rs. 24 lakh per annum) and the new statutory auditor appointment after the previous firm's term ended. The related party transaction limit of Rs. 5 crore with the wholly-owned subsidiary signals expected business activity growth in the subsidiary.